Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Walker

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitorsDustin L McMinn, Yosup Rew, Athena Sudom, et al.
Molecular Cancer Therapeutics|May 27, 2024
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid TumorsAmy E Anderson, Kaustubh Parashar, Ke Jin, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogsTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hitTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2009
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primatesJoyce C Y Chan, Derek E Piper, Qiong Cao, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitorsDustin L McMinn, Yosup Rew, Athena Sudom, et al.
Molecular Cancer Therapeutics|May 27, 2024
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid TumorsAmy E Anderson, Kaustubh Parashar, Ke Jin, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogsTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hitTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2009
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primatesJoyce C Y Chan, Derek E Piper, Qiong Cao, et al.
Pageof 5